Genizon Biosciences discovers genes and biomarkers in common diseases using genome-wide association studies.
Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2008 | Series E | $30.81M | 2 | Biotech Turnaround Fund (BTF) | — | Detail |
Feb 5, 2007 | Series D | $10M | 1 | — | — | Detail |
Mar 29, 2006 | Series Unknown | $12M | 2 | — | — | Detail |
Dec 13, 2004 | Series B | $11.10M | 1 | — | — | Detail |
Jan 7, 2004 | Series Unknown | $11.15M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Biotech Turnaround Fund (BTF) | Yes | Series E |
Investissement Desjardins | — | Series E |
MVI Finance | — | Series Unknown |
Biofund | — | Series Unknown |